TG-0054

· GPCR Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TG-0054, covering 2015-01-08 to 2017-12-13. Get the full timeline:

Most recent: Clinical Trial Update: PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]

See pricing